For research use only. Not for therapeutic Use.
Orexin 2 Receptor Agonist is a potent selective OX2R agonist with an EC50 of 23 nM[1].
Orexin 2 Receptor Agonist replaces Orexin-A to bind to hOX1R and hOX2R in a concentration-dependent manner in CHO cells overexpressing hOX1R and HEK-293 cells overexpressing hOX2R with Ki values of 0.14 μM and 0.77 μM, respectively[1].
Catalog Number | I002331 |
CAS Number | 1796565-52-0 |
Synonyms | N-[2-[3-[[5-[3-(dimethylcarbamoyl)phenyl]-2-methoxyphenyl]sulfonylamino]anilino]ethyl]-3-methylbenzamide |
Molecular Formula | C32H34N4O5S |
Purity | ≥95% |
InChI | InChI=1S/C32H34N4O5S/c1-22-8-5-10-25(18-22)31(37)34-17-16-33-27-12-7-13-28(21-27)35-42(39,40)30-20-24(14-15-29(30)41-4)23-9-6-11-26(19-23)32(38)36(2)3/h5-15,18-21,33,35H,16-17H2,1-4H3,(H,34,37) |
InChIKey | RHLMXWCISNJNDH-UHFFFAOYSA-N |
SMILES | CC1=CC(=CC=C1)C(=O)NCCNC2=CC(=CC=C2)NS(=O)(=O)C3=C(C=CC(=C3)C4=CC(=CC=C4)C(=O)N(C)C)OC |
Reference | [1]. Nagahara T, et al. Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists. J Med Chem. 2015 Oct 22;58(20):7931-7. |